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This study is concerned with the application of
the fluorescent antibody technic to the investi-
gation of the immunologic character of various
dermatological disorders.
We applied the direct immuno-fluorescent
method (1, 2), using fluorescein labelled anti-
human globulin and anti-human gamma globulin
to tissue sections cut from lesions and uninvolved
skin of patients with lupus erythematosus,
psoriasis, contact dermatitis, eezematous derma-
titis, nummular eczema, atopie dermatitis,
eczema solare, seborrheic dermatitis and mycosis
fungoides. Normal skin was used as controls.
The fluorescent antibody technic (3, 4, 5, 6, 7,
5) provides a visual localization of antigen or
antibody fixed to tissues and is an immunohisto-
chemical approach to the study of diverse disease
processes.
Recently fluorescent antibody studies have
been applied to dermatologieal problems. Raskin
(9) showed papillary dermal fluorescence in
in patients with rhus contact dermatitis by use
of the direct method, and she suggested this as
the antigen-antibody reaction site in this condi-
tion. Wise (10) reacted fluorescein labelled sera
with autologous skin. He found serum globulins
with a specific dermatitic skin affinity but non-
reactive against uninvolved skin in one atopic
patient and another with nummular eczema.
Our work demonstrated gamma globulin
localization in skin lesionswhieh at least suggested
an immunologic reaction associated with these
diseases.
To our knowledge the present report is the
first of the direct immuno-fluorescent method
applied to skin lesions of lupus erythematosus,
eczema solare, psoriasis, seborrheic dermatitis
and mycosis fungoides.
* From the Department of Dermatology,** and
Clinical Laboratories,*** Henry Ford Hospital,
Detroit, Michigan.Presented at the Twenty-fourth Annual Meet-
ing of The Society for Investigative Dermatology,
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MATERIALS AND METHODS
1. Clinical Material
Specimens of lesions were taken from 27 pa-
tients. These included 7 cases of psoriasis, 9 of
lupus erythematosus (6 with systemic lupus
erythematosus, including 2 with discoid lesions,
and 3 with chronic discoid lupus erythematosus
without systemic manifestations), 3 of atopic
dermatitis, 3 of mycosis fungoides and 1 each of
eczema solare, contact dermatitis, eczematoUs
dermatitis, nummular eczema and scborrbeic
dermatitis.
Uninvolved skin biopsy specimens were ob-
tained from 3 of the psoriatic patients and from
2 of the patients with lupus erythcmatosus, and
one from each of the patients with contact derma-
titis, atopic dermatitis and seborrhcic dermatitis.
Eight normal skin specimens and one intra-
dermal nevus were also studied.
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2. Preparation of Specimen
Full thickness elliptical biopsy specimens,
taken with 1% Xylocaine local anesthesia, were
immediately frozen in liquid nitrogen, stored at
—15°C and within one week were cut on a cryostat
at —15°C. The sections were placed on glass slides
and were stored at —15° C until they were used.
3. Preparation of Conjugate
Commercially prepared lyophillized fluorescein
labelled goat anti-human globulin and anti-human
gamma globulin* (absorbed once with rabbit liver)
was reconstituted as directed and aliquants were
frozen. Staining was carried out with a 1:10 dilu-
tion of the serum in buffered saline, pH 7.3, and
extracted once with ethyl acetate to remove any
dissociated fiuorescein. A modification of the
method used by Dinccn (11) was employed. On
two occasions, portions of the conjugate were
absorbed once with human liver in addition to the
rabbit liver absorption.
4. Staining and Examination
Immediately prior to staining, the slides were
washed in buffered saline to remove any unbound
globulin, than in distilled water and dried. Se-
lected slides ware first fixed for 15 minutes in 95%
ethyl alcohol. The specimens were covered with
* May be purchased from Baltimore Biological
Laboratories
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the prepared conjugate and incubated at 37° C
for thirty minutes ou a slowly rotating shaker,
washed again in buffered saline pH 7.3, water and
dried. The slides were examined without a cover
ilip using a Zeiss photomicroscope with an Osram
mercury HBO 200 watt light source, UG2 excita-
tion filter and a yellow barrier filter, with a wave-
length cut-off point of 4000 Angstroms.
Hematoxylin and eosin stained sections were
prepared of all specimen and PAS stains were
performed on selected ones. Some fiuorcscein con-
jugate staiaed slides were stained similarly in an
attempt to identify the structures producing the
selective localized fluorescence.
5. Selectivity Controls
A normal skin section was stained concurrently
with every experimental procedure. Selected
sections were incubated for thirty minutes with
unlabelled goat anti-human serum, goat anti-
human globulin, goat anti-human gamma globu-
lin, equine anti-human globulin and unlabelled
chicken anti-human albumin prior to staining
with the conjugate. Antigenic sites covered by
unlabelled antibody cannot react with labelled
antibody. Immunofluorescent selectivity is thus
established. In addition, 0.12 cc of human gamma
globulin was added to 2 cc of the 1:10 diluted
fluorescein labelled anti gamma globulin. This
was incubated at 37° C for one hour and allowed
to staad in the refrigerator overnight, and cen-
trifuged. The supernatant fluid was treated simi-
larly and was then used to stain selected sections.
Controls with human albumin added instead of
gamma globulin were employed. Some sections
were also stained with fluorescein labelled goat
anti-rabbit globulin and rabbit anti-human fi-
brinogen as additional controls.
Unstained sections were examined to ensure
that what appeared to be fluoresceia emission was
not in fact auto-fluorescence.
EE5ULTS
1. Unstained Sections
All sections showed blue-green auto-fluores-
cence of the epidermis and collagen bundles of
the dermis, with slightly brighter fluorescence
of elastic fibers. Bright yellow-green fluorescent
granules were noted in the epithelial cells of the
sweat glands. No areas of localized bright yellow-
green fluorescence were noted at the dermal-
epidermal junction or in the dermis. fIn 2 of the
unstained lupus erythematosus sections a blue-
green auto-fluorescent band was seen at the
dermal-epidermal junction, of the same color as
the collagen bundles.
2. Normal Skin
The dermis of all normal skin sections and the
intradermal nevus fluoresced diffusely with areas
of bright yellow-green, more pronounced in the
upper dermis (Fig. 1). No areas of localized
bright yellow-green fluorescence were noted at
the dermal-epidermal junction. The epidermis
demonstrated nonspecific green fluorescence only.
3. Lupus Erythematosus
Lesion sections from the 9 patients with lupus
erythematosus showed a striking well-demarcated
band of bright yellow-green fluorescence at the
dermal-epidermal junction, the site of the base-
ment membrane. At times the band was seen to
extend around the hair follicles. This band cor-
responded with the dark blue-green auto-fluores-
cent band seen at the dermal-epidermal junction
of unstained sections in the eases that showed
this. The dermis showed the diffuse and patchy
fluorescence of the normal skin sections (Fig. 2).
The fluorescent band at the dermal-epidermal
junction was seen irrespective of the area of the
body involved, including the scalp, face, arms
and anterior chest. One new arm lesion from a
patient whose older facial lesion demonstrated
the band, did not demonstrate this finding. The
band was seen in the presence and absence of
liquefaction degeneration of the basal layer.
The clinically uninvolved skin from 2 of the
lupus erythematosus patients, one of whom had
systemic involvement, did not show the fluores-
cent band at the junction and fluoresced like
normal skin sections.
Periodic acid Schiff staining at the site of the
fluorescent band at the dermal-epidermal junc-
tion confirmed that this fluorescence was at
the basement membrane site.
4. Psoriasis
The involved skin in all patients of this group
showed an ill-defined bright yellow-green fluores-
cent band at the dermal-epidermal junction,
outlining the papillae. This was quite different
due to its indistinct outline from the well-demar-
cated band seen in lupus erythematosus, and
was sometimes continuous with localized areas
of similar fluorescence immediately beneath it
(Fig. 3).
PAS stains were positive at part of the site
of the fluorescent band which outlined the
papillae, thus confirming that part of this fluores-
cence was at the basement membrane site.
The remainder of the dermis showed the diffuse
patchy yellowish green fluorescence seen in the
normal controls.
FIG. 1. Normal Skin, incubated with fluorescein labelled goat anti-human gamma globulin. Dif-
fuse patchy yellow-green fluorescence of the dermis is seen. No localized bright yellow-green
fluorescence is present at the dermal-epidermal junction. (Magnification X 100)
FIG. 2. Lu pus Erythematosus Lesion, incubated with fluorescein labelled goat anti-human gamma
globulin. This photograph shows a well-demarcated band of bright yellowish-green fluorescence
at the dermal-epidermal junction. Patchy yellow-green fluorescence is present in the dermis. (Mag-
nification X 250)
FIG. 3. Psoriasis Lesion, incubated with fluorescein labelled goat anti-human gamma globulin. A
poorly demarcated band of bright yellowish-green fluorescence is seen at the dermal-epidermaljunction outlining a papilla. This is continuous in isolated places with the patchy yellowish-green
fluorescence of the dermis. (Magnification X 100)
FIG. 4. Lu pus Erythematosus Lesion. (Same lesion as Figure 2.) Incubated with unlabelled equine
anti-human globulin prior to incubation with fluorescein labelled goat anti-human gamma globulin.
Complete block. No localized bright yellow-green fluorescence is present at the dermal-epidermaljunction. The patchy yellow-green fluorescence of the dermis is also absent. Residual nonspecific
fluorescence is present in the epidermis and dermis. (Magnification X 250) All photographs taken
with Super Anscochrome—daylight.
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The uninvolved skin specimens from 2 of the 3
psoriatic patients failed to show the localized
bright fluorescence at the dermal-epidermal
junction, whereas the third specimen showed the
fluorescence but less intensely. Diffuse patchy
yellowish green fluorescence in the dermis as shown
by the normal controls was present in all 4 speci-
mens.
5. Atopic Dermatitis, Eczematous Dermatitis,
Nummular Eczema, Contact Dermatitis,
Eczema Solare, Seborrheic Dermatitis
Specimens of lesions from 2 patients with
atopie dermatitis, and 1 each with contact der-
matitis, seborrheic derniatitis, eezematous der-
matitis and eczema solare showed an ill-defined,
bright yellow-green fluorescent band at the
dermal-epidermal junction, outlining the papil-
lae, similar to that seen in psoriasis, as well
as the diffuse patchy yellow-green fluorescence
of the remainder of the dermis. The unin-
volved skin specimens of one of the patients
with atopic dermatitis and each of the patients
with seborrheic dermatitis and contact dermatitis
fluoresced similarly to normal skin. The lesions
from one patient with atopic dermatitis and the
patient with nummular eczema failed to demon-
strate the fluorescent band, hut still fluoresced
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brightly in localized areas at the dermal-cpidcr-
mal junction.
FAS stains again confirmed the basement mem-
brane site of part of the dermal-epidermal junc-
tional fluorescence in this group.
6. Mycosis Fungoides
The lesions from the 3 mycosis fungoides pa-
tients, 2 in the tumor stage with erythroderma
and 1 with generalized erythroderma only, all
exhibited areas of localized bright yellow-green
fluorescence at the dermal-epidermal junction.
A fairly well-demarcated, weakly fluorescent
band was seen at this site in 1 of the patients in
the tumor stage. Small round fluorescent bodies
were seen in the epidermis and upper dermis.
Attempts to identify these with the abnormal
cellular infiltrate by staining with hematoxylin
and eosin were unsuccessful, although they
occurred in the areas of the infiltrate.
7. Selectivity Controls
The localized fluorescence at the dermal-
epidermal junction in lesions, and the diffuse
patchy fluorescence of the dermis in lesions,
uninvolved and normal skin was partially or
completely blocked by prior incubation with un-
conjugated goat anti-human serum, goat anti-
human globulin, goat anti-human gamma glob-
ulin and equine anti-human globulin (Fig. 4),
but not by chicken anti-human albumin. The
cpidcrmal fluorescence was not blocked. Com-
plete blocking occurred with the supernatant of
fluorescein labelled anti-human gamma globulin
previously incubated with human gamma glob-
ulin, but not with the human albumin.
The sections stained with fluorescein labelled
goat anti-rabbit globulin and rabbit anti-human
fibrinogen also failed to show any localized
fluorescence, The immunologic selectivity of the
fluorescence was thus established.
8. Variations of Staining Procedures
No significant difference was observed between
the stained unfixed and ethyl alcohol fixed
sections.
Human liver absorption of the conjugate
removed the epidcrmal fluorescence partially or
entirely, confirming its non-specificity. The
dermal and junctional fluorescence was un-
changed.
Sections stained with fluorescein labelled goat
anti-human gamma globulin fluoresced in the
same manner as those stained with labelled
goat anti-human globulin.
DISCUSSION
This investigation demonstrated gamma glob-
ulin localization at the dermal-epidermal junc-
tion in lupus erythematosus, psoriasis, contact
dermatitis, atopic dermatitis, eczematous derma-
titis, nummular eczema, eczema solare, seborrheic
dermatitis and erythroderma associated with
mycosis fungoides.
In lupus crythematosus the striking fluores-
cence of the basement membrane is reminiscent
of Mellors' (8) finding of localized gamma glob-
ulin in renal glomerular lesions corresponding
to the presence of PAS positive material at
these sites.
The well defined, brightly fluorescent band at
the dermal-epidermal junction was a consistent
finding in the lupus erythematosus lesions, and
was not as intense or as sharply demarcated in
any of the other conditions.
The absence of the fluorescent band in a new
lesion from a lupus erythematosus patient whose
older lesion demonstrated the fluorescent band
suggests that gamma globulin localization at the
dermal-epidermal junction may be a continuous
process increasing with the age of the lesion.
The bright fluorescence in areas of abnormal
cellular infiltration in mycosis fungoidcs could
represent either gamma globulin produced by
these cells or bound to them as a result of a
reaction between them and circulating gamma
globulin.
The diffuse patchy yellowish-green fluores-
cence in the' dermis of the normal controls has
been previously reported by Gitlin (12), and
indicates the presence of globulins at this site.
No bright localized fluorescence at the dermal-
epidermal junction was noted, however, in any
of the normal specimens.
Gamma globulin localized at the dermal-
epidermal junction suggests that this may be the
site of an antigen-antibody reaction. Gamma
globulin may represent antibody to skin (or skin
plus hapten in contact dermatitis) in these various
dermatoses, produced locally or at distant sites,
by abnormal clones of cells against normal or
altered tissues (13, 14, 15, 16, 17).
However, the mere presence of gamma globulin
localized at these sites does not necessarily prove
that an antigen-antibody reaction has occurred;
it is merely presumptive evidence. One could
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argue that gamma globulin localization may be
secondary to the primary process responsible
for the development of the lesion, whatever that
may be. In an attempt to determine the immuno-
logic significance of gamma globulin localization
at the dermal-epidcrmal junction, we performed
the following experiments:
1. Incubation with Skin Homogenate
If the gamma globulin localized at the dermal-
epidermal junction represents antibody to skin
components, then it might be possible to demon-
strate a difference in its immunologic reactivity
to a skin homogenate representing antigen, com-
pared to that of the gamma globulin present in
the dermis in lesions and in the normal controls.
Quick frozen normal and uninvolved skin was
homogenized in a glass tissue grinder at 00 C.
utilizing buffered saline pH 7.3. The super-
natant was incubated with the skin sections
prior to staining with labelled antibody. This
was an attempt to determine whether localized
gamma globulin would demonstrate reactivity
with the skin homogenate antigen. If this were the
case, no further reaction with labelled antigamma
globulin should occur. No difference was seen in
the fluorescence between sections first incubated
with the skin homogenate and those not so
treated.
Proof that the localized gamma globulin has
no immunologic character is not clearly estab-
lished by this experiment. Any existing antibody
sites of the gamma globulin may already have
been satisfied, or antigenic groups of the gamma
globulin may still be available to react with anti-
gamma globulin even though the antibody
groups are satisfied.
2. Incubation with Guinea Pig Complement
If the gamma globulin is localized because of
a reaction with antigen in situ then there is a
possibility of concomitant local complement
binding (18). On the remote chance that addi-
tional complement might be bound to the antigen
antibody complex, we added guinea pig comple-
ment to sections.
Representative sections were incubated with
guinea pig complement for 24 hours at 40 C.
The slides were then washed and stained with
fluorescein labelled rabbit anti-guinea pig serum
as described previously. If complement had been
bound by the gamma globulin at the dermal-
cpidcrmal junction then fluorescence would be
expected at this site.
No fluorescence was seen in any of the sections.
There was DO evidence of guinea pig comple-
ment binding at the dcrmal-epidermal junction.
Again, the lack of the immunologic character
of the localized gamma globulin is not established
by this experiment. The negative result could be
due either to the antigen-antibody complex being
already satisfied with complement, or because
complement binding does not occur in the
reaction.
CONCLUSION
Localization of gamma globulin at the dermal-
epidermal junction in these diseases, although
suggestive of an antigen-antibody reaction at
this site, is not proof of an immunologic reaction of
this type.
This problem needs further investigation,
possibly along the lines of the work of \\Tise (10)
who found globulins reactive against diseased
skin in the sera of 2 of his patients. We are pres-
ently embarking upon experiments along these
lines.
5UMMARY
The fluorescent antibody technic was applied
to lesion biopsy specimens of 27 patients with
various dermatoses and to biopsy specimens of
normal skin from 8 patients and one intradermal
nevus.
Lesions of patients with lupus erythematosus,
psoriasis and various dermatoses were stained by
the direct immunofluorescent method. Com-
mercially prepared fluorescein labelled goat
anti-human globulin and fluoresccin labelled
goat anti-human gamma globulin were employed.
Localized bright yellow-green fluorescence was
demonstrated at the dermal-epidermal junction,
with diffuse patchy yellow-green fluorescence in
the dermis in the various diseases studied. Lupus
erythcmatosus lesions consistently showed a
well-demarcated bright yellow-green fluorescent
band at the basement membrane site, Although
a brightly fluorescent but ill-defined band was also
present at the dermal-epidermal junction in the
other diseases, this was rather poorly-demarcated
and much less distinct than the well-demarcated
band seen in the lupus erythematosus lesions.
Normal skin and the intradermal nevus showed
only the diffuse patchy yello\v-grecn fluorescence
in the dermis seen at this site in the lesions.
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Controls confirmed the immunologic selectivity
of the fluorescence. Gamma globulin localization
was thus demonstrated at the dermal-epidermal
junction, suggesting, but by no means proving,
this as the site of an antigen-antibody reaction in
the various dermatoses.
Further experiments to determine the immuno-
logic significance of gamma globulin localization
at the dermal-epidermal junction were performed
with inconclusive results.
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DISCUSSION
Da. W. KENNETH BLAvLOCK (Bethesda, Md.):
I would like to ask two questions: one, was rhoda.
mine bovine serum albumin used as a back-
ground counterstain in any of these sections, and,
second, is it not true that the dermal-epidermal
junction fluoresces nonspecifically when you use
the conjugated serum on these tissue sections?
DR. THoMAs K. BUENHAM (in closing): I
would like to thank the discussers.
In answer to Dr. Blaylock, we used rhodamine-
labelled bovine albumin initially, but once we
knew where to look for this yellow-green fluores-
cence and what to expect, we found that this
method did not present sufficient advantage to
use routinely. Omission of this procedure did
not materially alter the definition of the fluores-
cence at the junction.
In answer to the second somewhat loaded
question "Is this dermal-epidermal junctional
fluorescence not found with any conjugated
antiserum?" My answer to that is no, because,
first of all, as I showed you, the normal skin sec-
tions and we had many — I think that we had
eight different specimens each stained numerous
times — did not show localized dermal-epidermal
junctional fluorescence.
Secondly, we had additional controls in that we
used conjugated goat anti-rabbit globulin and
conjugated rabbit anti-human fibrinogen, both
of which failed to produce the localized fluores-
cence at the dermal-epidermal junction in lesion
sections. This further confirmed the selectivity
of the junctional fluorescence in the latter.
